Saturday, January 16, 2016 3:48:46 PM
Wha? LMFAO. That's not what he said at all. He did state that new collaberations will be announced in Q1. And by implication and as explicitly stated RGBP would no longer have to pay with discounted shares anymore. That is close to saying that he will announce funded big name partners that will eliminate the need to pay with shares anymore. Now it's the act of a successful person early in a new leadership position to get a couple of big wins quickly. For him to publicly predict that these partnerships will be announced in the next 76 days means they are close or done already. I'd say now is the BEST time to buy.
Why is the SP going down? IDK but is seems reasonable that someone needing cash and owns shares at 2 or 3 cents a share would be happy to get their cash out at 10, 11, or 12 cents a share.
I still think the first PR will be about the NIH. I believe it's being reviewed or has just been approved by the NIH and I believe it will clarify, in favor of RGBP that NIH is funding the collaboration. I'm hoping that stops the bleeding. But the big announcement will be one with a recognizable, profitable BP or Biotech. That's when I think the SP takes off. And I think that happens before end of Feb.
Why is the SP going down? IDK but is seems reasonable that someone needing cash and owns shares at 2 or 3 cents a share would be happy to get their cash out at 10, 11, or 12 cents a share.
I still think the first PR will be about the NIH. I believe it's being reviewed or has just been approved by the NIH and I believe it will clarify, in favor of RGBP that NIH is funding the collaboration. I'm hoping that stops the bleeding. But the big announcement will be one with a recognizable, profitable BP or Biotech. That's when I think the SP takes off. And I think that happens before end of Feb.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
